Related Experiment Videos
Substance P reduces tail-flick latency: implications for chronic pain syndromes
Kiran Yasphal1, D M Wright, J L Henry
1Department of Psychiatry, McGill University, Montreal, Que. H3G 1Y6 Canada Department of Research in Anaesthesia, McGill University, Montreal, Que. H3G 1Y6 Canada.
Pain
|October 1, 1982
Summary
Substance P administered intrathecally in rats reduced pain reaction times, suggesting it plays a role in pain pathways. This research proposes substance P involvement in chronic pain conditions.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Substance P is a neuropeptide implicated in pain signaling.
- Understanding the role of substance P in pain perception is crucial for developing pain management strategies.
Purpose of the Study:
- To investigate the effects of intrathecal administration of substance P and eledoisin-related peptide (ERP) on pain responses in rats.
- To explore the potential role of substance P in the mechanisms of acute and chronic pain.
Main Methods:
- Awake restrained rats were administered substance P or ERP intrathecally.
- Pain response was measured using the tail-flick test following noxious radiant heat stimulus.
- Behavioral changes were observed and reaction times recorded.
Main Results:
- Intrathecal substance P and ERP significantly reduced tail-flick latency, indicating decreased pain threshold.
- High doses of peptides induced behavioral responses suggestive of perceived pain.
- Substance P was found to be approximately four times more potent than ERP.
Conclusions:
- The findings support the role of substance P as an excitatory agent in spinal sensory pathways for pain.
- Excessive spinal substance P may contribute to chronic pain conditions.
- Receptor supersensitivity to substance P is also proposed as a mechanism for certain chronic pain states.